Department of Conservative Dentistry and Endodontics, Faculty of Dental Medicine, College of Health Sciences, International University of Rabat, Rabat, Morocco.
Department of Conservative Dentistry and Endodontics, Faculty of Dentistry, University Cheikh Anta Diop, Dakar, Senegal.
Aust Endod J. 2023 Sep;49 Suppl 1:488-493. doi: 10.1111/aej.12694. Epub 2022 Sep 23.
Pulpotomy has been used in primary teeth and immature permanent teeth. However, with the advent of new bioactive material, the procedure is shifting towards permanent teeth with mature apices of roots. The objective of this systematic review was to evaluate the success of pulpotomy on mature permanent teeth with acute irreversible pulpitis and to compare it with root canal treatment or between the effectiveness of the bioactive material used. The following databases were searched: PubMed, Cochrane Library: Cochrane Central Register of Controlled Trials, Embase, ClinicalTrials.gov, International Clinical Trials Registry Platform. After using the keywords predefined, the electronic search yielded a total of 86 articles. After undergoing a thorough screening and eligibility process, only four articles were finally selected. Unexpectedly, pulpotomy demonstrated a better tendency for success in such cases over the years. This shows that pulpotomy is not inferior to root canal treatment for permanent treatment of irreversible pulpitis. In addition, the results obtained showed that pulpotomy is rapid, biologically reliable and more cost-effective in all situations compared to root canal therapy. Complete pulpotomy appears to have a high success rate as a permanent treatment of irreversible pulpitis and could be considered as an alternative to root canal therapy. Pulpotomy is not inferior to root canal treatment for a permanent treatment of irreversible pulpitis. In addition, the results obtained have shown that complete pulpotomy is faster and more profitable in all situations compared to root canal treatment. Furthermore, with the advent of new so-called bioactive materials, the use of this therapeutic is increasingly considered. This is why a review based on studies of reliable articles is above all necessary to be able to generalise the indication of this therapy.
活髓切断术已应用于乳牙和未成熟恒牙。然而，随着新型生物活性材料的出现，该手术逐渐转向根尖发育完成的恒牙。本系统评价的目的是评估在有急性不可复性牙髓炎的成熟恒牙上进行活髓切断术的成功率，并将其与根管治疗进行比较，或比较使用的生物活性材料的有效性。检索了以下数据库：PubMed、Cochrane 图书馆：Cochrane 对照试验中心注册库、Embase、ClinicalTrials.gov、国际临床试验注册平台。使用预定义的关键词进行电子搜索后，共得到 86 篇文章。经过全面筛选和资格审查，最终仅选择了 4 篇文章。出乎意料的是，多年来，活髓切断术在这种情况下显示出更好的成功趋势。这表明活髓切断术在恒牙不可逆性牙髓炎的永久治疗方面并不逊于根管治疗。此外，研究结果表明，与根管治疗相比，活髓切断术在所有情况下都更快、更具生物学可靠性且更具成本效益。完全活髓切断术似乎作为不可逆性牙髓炎的永久性治疗具有较高的成功率，可作为根管治疗的替代方法。活髓切断术在恒牙不可逆性牙髓炎的永久治疗方面并不逊于根管治疗。此外，研究结果表明，与根管治疗相比，完全活髓切断术在所有情况下都更快且更具经济效益。此外，随着新型所谓生物活性材料的出现，这种治疗方法的应用越来越受到重视。因此，基于可靠文章的研究进行综述是必要的，以便能够将该疗法的适应证进行概括。
